Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
26.50
-0.14 (-0.53%)
At close: Jul 2, 2026, 4:00 PM EDT
25.99
-0.51 (-1.92%)
After-hours: Jul 2, 2026, 7:21 PM EDT
Alumis Employees
As of March 31, 2026, Alumis had 227 total employees, including 225 full-time and 2 part-time employees. The number of employees increased by 3 or 1.34% since the number was last reported on December 31, 2025.
Employees
227
Change
3
Growth
1.34%
Revenue / Employee
$37,013
Profits / Employee
-$1,045,881
Market Cap
3.38B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 227 | 3 | 1.34% | 225 | 2 |
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Celldex Therapeutics | 198 |
| Catalyst Pharmaceuticals | 182 |
ALMS News
- 8 days ago - Alumis management to meet with Cantor - TheFly
- 22 days ago - Alumis rises 10.3% - TheFly
- 6 weeks ago - Alumis price target raised to $40 from $38 at Chardan - TheFly
- 6 weeks ago - Alumis Proxy statement: Proxy filing - Filings
- 6 weeks ago - Alumis Proxy statement: Proxy filing - Filings
- 7 weeks ago - Alumis price target raised to $39 from $38 at Morgan Stanley - TheFly
- 7 weeks ago - Alumis price target raised to $51 from $49 at Wells Fargo - TheFly
- 7 weeks ago - Alumis Slides: Corporate presentation - Filings